Tokyo - Delayed Quote JPY
Takeda Pharmaceutical Company Limited (4502.T)
4,234.00
-46.00
(-1.07%)
At close: May 9 at 3:30:00 PM GMT+9
Major Holders
Breakdown | |
---|---|
0.03% | % of Shares Held by All Insider |
46.38% | % of Shares Held by Institutions |
46.40% | % of Float Held by Institutions |
428 | Number of Institutions Holding Shares |
Top Institutional Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
Pacer Advisors, Inc. | 847.75k | Mar 31, 2025 | 0.05% | 3,589,381,968 |
Paradigm Asset Management Company, LLC | 46.6k | Mar 31, 2025 | 0.00% | 197,304,400 |
Top Mutual Fund Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund | 21.75M | Jan 31, 2025 | 1.37% | 92,105,783,964 |
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund | 13.42M | Dec 31, 2024 | 0.84% | 56,826,766,488 |
CAPITAL WORLD GROWTH & INCOME FUND | 12.91M | Mar 31, 2025 | 0.81% | 54,665,982,694 |
iShares Trust-iShares Core MSCI EAFE ETF | 10.06M | Mar 31, 2025 | 0.63% | 42,576,595,920 |
Capital Income Builder | 7.3M | Mar 31, 2025 | 0.46% | 30,923,230,700 |
iShares, Inc.-iShares MSCI Japan ETF | 5.78M | Mar 31, 2025 | 0.36% | 24,482,681,600 |
iShares Trust-iShares MSCI EAFE ETF | 5.29M | Mar 31, 2025 | 0.33% | 22,416,108,540 |
INVESTMENT CO OF AMERICA | 5.22M | Mar 31, 2025 | 0.33% | 22,080,360,808 |
Fidelity Concord Street Trust-Fidelity International Index Fund | 5.11M | Mar 31, 2025 | 0.32% | 21,640,537,122 |
-Price (T.Rowe) International Value Equity Trust | 4.6M | Dec 31, 2024 | 0.29% | 19,465,391,600 |
Related Tickers
GALD.SW Galderma Group N
99.75
+1.42%
4506.T Sumitomo Pharma Co., Ltd.
964.00
+4.56%
MKKGY Merck KGaA
27.84
+0.14%
PPGN.SW PolyPeptide Group AG
20.15
+2.28%
SOBI.ST Swedish Orphan Biovitrum AB (publ)
299.80
+0.67%
SDZ.SW Sandoz Group AG
38.03
+2.07%
UTHR United Therapeutics Corporation
301.42
-2.14%
KNSA Kiniksa Pharmaceuticals International, plc
26.03
-2.58%
EOLS Evolus, Inc.
9.80
-2.87%
NBIX Neurocrine Biosciences, Inc.
115.71
-1.54%